Search
Arrowhead Pharmaceuticals Inc
ARWRAdd to Watchlist
84.650USD
-2.670-3.06%
Close 07-31 16:00（ET）Quotes delayed by 15 min
11.92BMarket Cap
LossP/E TTM
Arrowhead Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Arrowhead Pharmaceuticals Inc is 7.14, ranking 209 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -37.28, which is -232.76% below the recent high of 49.49 and -15963.53% above the recent low of -5988.52.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.